Reference health

Tumor Glycolytic Profiling Through 18F-FDG PET/CT Predicts Immune Checkpoint Inhibitor Efficacy in Advanced NSCLC

https://doi.org/10.2139/ssrn.4114254
CiteStamped reference-health badge
23/23 checkable references clean · checked 2026-08-29

Every reference with a DOI in the deposited reference list resolved to a known work in Crossref or DataCite at the dated check, and none carried a retraction, withdrawal, or removal notice.

2 without a DOI — not checked. A reference deposited without a DOI is never matched by title or guessed at; it stays outside the checked set, and this line discloses that.

The 23 checked references that resolve
resolves10.1038/s41571-021-00520-1
Selecting the optimal immunotherapy regimen in driver-negative metastatic NSCLC
resolves10.1002/cncr.32468
Biomarkers for immune checkpoint inhibition in non–small cell lung cancer (NSCLC)
resolves10.1016/j.cell.2011.02.013
Hallmarks of Cancer: The Next Generation
resolves10.1038/nrc1478
Why do cancers have high aerobic glycolysis?
resolves10.1016/j.cell.2015.08.016
Metabolic Competition in the Tumor Microenvironment Is a Driver of Cancer Progression
resolves10.1016/j.cell.2013.05.016
Posttranscriptional Control of T Cell Effector Function by Aerobic Glycolysis
resolves10.1016/j.cell.2015.08.012
Phosphoenolpyruvate Is a Metabolic Checkpoint of Anti-tumor T Cell Responses
resolves10.1016/j.ejca.2008.10.026
New response evaluation criteria in solid tumours: Revised RECIST guideline (version 1.1)
resolves10.1007/s13139-017-0493-6
Current Methods to Define Metabolic Tumor Volume in Positron Emission Tomography: Which One is Better?
resolves10.1148/radiol.12111148
Prognostic Value of Whole-Body Total Lesion Glycolysis at Pretreatment FDG PET/CT in Non–Small Cell Lung Cancer
resolves10.1038/nrc3038
Otto Warburg's contributions to current concepts of cancer metabolism
resolves10.1016/j.cmet.2016.12.018
Foxp3 Reprograms T Cell Metabolism to Function in Low-Glucose, High-Lactate Environments
resolves10.1038/nri3862
Molecular and cellular insights into T cell exhaustion
resolves10.3892/or.2022.8266
Advances in metformin‑based metabolic therapy for non‑small cell lung cancer (Review)
resolves10.3390/jcm9030725
Potential of FDG-PET as Prognostic Significance after anti-PD-1 Antibody against Patients with Previously Treated Non-Small Cell Lung Cancer
resolves10.1016/j.ejca.2021.03.020
Baseline total metabolic tumour volume on 2-deoxy-2-[18F]fluoro-d-glucose positron emission tomography-computed tomography as a promising biomarker in patients with advanced non–small cell lung cancer treated with first-line pembrolizumab
resolves10.3390/cancers13071634
Metabolic Parameters as Biomarkers of Response to Immunotherapy and Prognosis in Non-Small Cell Lung Cancer (NSCLC): A Real World Experience
resolves10.1038/s41598-020-71735-y
Tumor metabolic volume by 18F-FDG-PET as a prognostic predictor of first-line pembrolizumab for NSCLC patients with PD-L1 ≥ 50%
resolves10.1007/s12149-020-01539-7
FDG-PET biomarkers associated with long-term benefit from first-line immunotherapy in patients with advanced non-small cell lung cancer
resolves10.1136/jitc-2020-000645
Baseline metabolic tumor volume as a strong predictive and prognostic biomarker in patients with non-small cell lung cancer treated with PD1 inhibitors: a prospective study
resolves10.3390/cancers13236096
First-Line Pembrolizumab Mono- or Combination Therapy of Non-Small Cell Lung Cancer: Baseline Metabolic Biomarkers Predict Outcomes
resolves10.3390/cancers12051163
18F-FDG Pet Parameters and Radiomics Features Analysis in Advanced Nsclc Treated with Immunotherapy as Predictors of Therapy Response and Survival
resolves10.1007/s00259-019-04615-x
Baseline metabolic tumor burden on FDG PET/CT scans predicts outcome in advanced NSCLC patients treated with immune checkpoint inhibitors
The 2 references without a DOI — listed, not checked
no DOI — not checkedRacker E. Bioenergetics and the problem of tumor growth
no DOI — not checkedA combined PET/CT scanner for clinical oncology
What this badge says. CiteStamped means the CHECKABLE references of this work were clean at the dated check: each resolved to a known work in a public registry, and none carried a retraction notice at that time. It says nothing about the quality, findings, or importance of the work itself, and nothing about references deposited without a DOI.

checked 2026-08-29 — re-checked daily as this page is visited; titles and statuses come from Crossref and DataCite and are not part of the signed record

Embed this badge

Both snippets point at the live badge image and link back to this page. The badge re-renders from the daily check, so an embed never goes stale by more than a day of visits.

<a href="https://citestamp.com/citestamped/10.2139/ssrn.4114254"><img src="https://citestamp.com/citestamped/10.2139/ssrn.4114254/badge.svg" alt="CiteStamped reference-health badge" width="460" height="64"></a>
[![CiteStamped reference-health badge](https://citestamp.com/citestamped/10.2139/ssrn.4114254/badge.svg)](https://citestamp.com/citestamped/10.2139/ssrn.4114254)